The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2020
Filed:
Feb. 15, 2017
Applicant:
Samsung Life Public Welfare Foundation, Seoul, KR;
Inventors:
Do-Hyun Nam, Seoul, KR;
Hyunkyu Park, Seoul, KR;
Assignee:
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, Seoul, KR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); C12N 15/63 (2006.01); A61K 47/68 (2017.01); G01N 33/574 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 47/6819 (2017.08); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C12N 15/63 (2013.01); G01N 33/574 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/71 (2013.01);
Abstract
The present invention relates to an antibody or antigen-binding fragment thereof against EGFRvIII (Epidermal Growth Factor Receptor Variant III), a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or antigen-binding fragment thereof, a composition for preventing or treating cancer, which comprises the same, a composition for diagnosing cancer, which comprises the same, and a kit for diagnosing cancer, which comprise the composition for diagnosing cancer.